ES2094840T3 - 1-(pirido(3,4-b)-1,4-oxazinil-4-il)-1h-indoles, compuestos intermedios y un procedimiento para su preparacion, y su uso como medicamentos. - Google Patents

1-(pirido(3,4-b)-1,4-oxazinil-4-il)-1h-indoles, compuestos intermedios y un procedimiento para su preparacion, y su uso como medicamentos.

Info

Publication number
ES2094840T3
ES2094840T3 ES92106160T ES92106160T ES2094840T3 ES 2094840 T3 ES2094840 T3 ES 2094840T3 ES 92106160 T ES92106160 T ES 92106160T ES 92106160 T ES92106160 T ES 92106160T ES 2094840 T3 ES2094840 T3 ES 2094840T3
Authority
ES
Spain
Prior art keywords
hydrogen
lower alkyl
medicines
oxazinil
pirido
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92106160T
Other languages
English (en)
Spanish (es)
Inventor
Richard Charles Effland
Larry Davis
Gordon Edward Olsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of ES2094840T3 publication Critical patent/ES2094840T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES92106160T 1991-04-15 1992-04-09 1-(pirido(3,4-b)-1,4-oxazinil-4-il)-1h-indoles, compuestos intermedios y un procedimiento para su preparacion, y su uso como medicamentos. Expired - Lifetime ES2094840T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/684,758 US5214038A (en) 1991-04-15 1991-04-15 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles and intermediates for the preparation thereof

Publications (1)

Publication Number Publication Date
ES2094840T3 true ES2094840T3 (es) 1997-02-01

Family

ID=24749434

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92106160T Expired - Lifetime ES2094840T3 (es) 1991-04-15 1992-04-09 1-(pirido(3,4-b)-1,4-oxazinil-4-il)-1h-indoles, compuestos intermedios y un procedimiento para su preparacion, y su uso como medicamentos.

Country Status (22)

Country Link
US (3) US5214038A (enExample)
EP (1) EP0509400B1 (enExample)
JP (1) JP2608359B2 (enExample)
KR (1) KR100201509B1 (enExample)
AT (1) ATE140006T1 (enExample)
AU (1) AU643135B2 (enExample)
CA (1) CA2065986C (enExample)
CZ (1) CZ282054B6 (enExample)
DE (1) DE69211892T2 (enExample)
DK (1) DK0509400T3 (enExample)
ES (1) ES2094840T3 (enExample)
FI (1) FI97544C (enExample)
GR (1) GR3020612T3 (enExample)
HU (1) HUT62588A (enExample)
IE (1) IE74907B1 (enExample)
IL (1) IL101589A (enExample)
NO (1) NO301765B1 (enExample)
NZ (2) NZ248131A (enExample)
PL (1) PL168671B1 (enExample)
RU (1) RU2042680C1 (enExample)
TW (1) TW211016B (enExample)
ZA (1) ZA922721B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5360811A (en) * 1990-03-13 1994-11-01 Hoechst-Roussel Pharmaceuticals Incorporated 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and related compounds as anti-inflammatory agents
US5264442A (en) * 1990-08-13 1993-11-23 Hoechst-Roussel Pharmaceuticals Incorporated Carbamoyl-1-(pyridinylalkyl)-1H-indoles, indolines and related analogs
GB9225859D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment
US5356910A (en) * 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder
GB9521680D0 (en) * 1995-10-23 1996-01-03 Orion Yhtymo Oy New use of imidazole derivatives
GB0119435D0 (en) * 2001-02-15 2001-10-03 Aventis Pharm Prod Inc Method of treating of demyelinating diseases or conditions
JP4292402B2 (ja) * 2001-09-07 2009-07-08 小野薬品工業株式会社 インドール誘導体化合物、それらの製造方法およびそれらを有効成分として含有する薬剤
GT200500063A (es) * 2004-04-01 2005-10-14 Metodo para tratar la esquizofrenia y/o anormalidades glucoregulatorias
CN102333761B (zh) 2009-01-28 2017-12-19 卡鲁斯治疗有限公司 Scriptaid电子等排体及其在治疗中的用途
IN2015DN03235A (enExample) * 2012-11-07 2015-10-02 Karus Therapeutics Ltd
KR20160007577A (ko) 2013-05-10 2016-01-20 카루스 떼라퓨틱스 리미티드 신규한 히스톤 디아세틸라제 억제제들
GB201419228D0 (en) 2014-10-29 2014-12-10 Karus Therapeutics Ltd Compounds
GB201419264D0 (en) 2014-10-29 2014-12-10 Karus Therapeutics Ltd Compounds
LT3837263T (lt) 2018-08-13 2024-09-25 F. Hoffmann-La Roche Ag Nauji heterocikliniai junginiai kaip monoacilglicerolio lipazės inhibitoriai
WO2021048242A1 (en) 2019-09-12 2021-03-18 F. Hoffmann-La Roche Ag 4,4a,5,7,8,8a-hexapyrido[4,3-b][1,4]oxazin-3-one compounds as magl inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029657A (en) * 1976-06-14 1977-06-14 The Dow Chemical Company 6,7-Dichloro-3,4-dihydro-2H-pyrazino(2,3-B)(1,4)oxazines
DE2726437A1 (de) * 1977-06-11 1978-12-21 Bayer Ag Hydrazonfarbstoffe
US4880822A (en) * 1987-04-24 1989-11-14 Hoechst-Roussel Pharmaceuticals, Inc. N-(pyridinyl)-1H-indol-1-amines
ATE115143T1 (de) * 1987-04-24 1994-12-15 Hoechst Roussel Pharma N-(pyridinyl)-1h-indol-1-amine, verfahren zu deren herstellung und ihre verwendung als arzneimittel.
US4970218A (en) * 1987-04-24 1990-11-13 Hoechst-Roussel Pharmaceuticals Inc. N-(pyridinyl)-1H-indol-1-amines
US5039811A (en) * 1987-04-24 1991-08-13 Hoechst-Roussel Pharmaceuticals Inc. Preparation of N-(pyridinyl)-1H-indol-1-amines
US4916135A (en) * 1989-05-08 1990-04-10 Hoechst Roussel Pharmaceuticals Inc. N-heteroaryl-4-quinolinamines
DE69016531T2 (de) * 1989-08-02 1995-07-06 Hoechst Roussel Pharma 2,3-Dihydro-1-(pyridinylamino)-indole, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel.
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones
US4983608A (en) * 1989-09-05 1991-01-08 Hoechst-Roussell Pharmaceuticals, Inc. N-substituted-4-pyrimidinamines and pyrimidinediamines

Also Published As

Publication number Publication date
GR3020612T3 (en) 1996-10-31
RU2042680C1 (ru) 1995-08-27
NZ242309A (en) 1995-07-26
IE921190A1 (en) 1992-10-21
IL101589A0 (en) 1992-12-30
TW211016B (enExample) 1993-08-11
CA2065986A1 (en) 1992-10-16
IE74907B1 (en) 1997-08-13
US5214038A (en) 1993-05-25
EP0509400B1 (en) 1996-07-03
CZ282054B6 (cs) 1997-05-14
AU1485292A (en) 1992-10-22
KR100201509B1 (ko) 1999-06-15
IL101589A (en) 1996-10-31
FI97544B (fi) 1996-09-30
JP2608359B2 (ja) 1997-05-07
PL294221A1 (en) 1993-08-09
DK0509400T3 (da) 1996-10-28
NO921490L (no) 1992-10-16
HUT62588A (en) 1993-05-28
FI921641A0 (fi) 1992-04-13
HU9201290D0 (en) 1992-07-28
ATE140006T1 (de) 1996-07-15
CA2065986C (en) 2006-02-21
EP0509400A1 (en) 1992-10-21
NZ248131A (en) 1995-07-26
PL168671B1 (pl) 1996-03-29
DE69211892T2 (de) 1996-12-19
US5276156A (en) 1994-01-04
AU643135B2 (en) 1993-11-04
NO921490D0 (no) 1992-04-14
US5519131A (en) 1996-05-21
FI921641A7 (fi) 1992-10-16
DE69211892D1 (de) 1996-08-08
FI97544C (fi) 1997-01-10
NO301765B1 (no) 1997-12-08
ZA922721B (en) 1992-11-25
JPH05112572A (ja) 1993-05-07
KR920019796A (ko) 1992-11-20
CS113592A3 (en) 1992-11-18

Similar Documents

Publication Publication Date Title
ES2094840T3 (es) 1-(pirido(3,4-b)-1,4-oxazinil-4-il)-1h-indoles, compuestos intermedios y un procedimiento para su preparacion, y su uso como medicamentos.
ES2112830T3 (es) 4-pirimidinaminas y -pirimidindiaminas sustituidas en n, un procedimiento para su preparacion y su uso como medicamentos.
CA2066640A1 (en) Heterocyclic compounds
BG66094B1 (bg) Азабициклени съединения, тяхното получаване и използване като лекарствени средста, по-специално като антибактериални средства
PE20020221A1 (es) CARBAMATOS AZABICICLICOS COMO AGONISTAS DEL RECEPTOR DE ACETILCOLINA NICOTINICO alfa 7
ES2111650T3 (es) Derivados aciclicos de etilenodiamina como antagonistas de receptores de la sustancia p.
ES2003671A6 (es) Un procedimiento para preparar derivados de dihidrobenzo-furano- y cromano-carboxamidas
BE1002213A5 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments.
MX21088A (es) N-heteroanil-purin-6-aminas, y un proceso para su preparacion y su uso como medicamentos.
ES2121761T3 (es) Carbamatos sustituidos de 1-(piridinilamino sustituido)-1h-indol-5-ilo, un procedimiento para su preparacion y su uso como medicamentos.
ES2065478T3 (es) 2-amino-1,2,3,4-tetrahidronaftalenos y 3-aminocromanos sustituidos en el anillo.
ATE66913T1 (de) Amidverbindungen, verfahren zu ihrer herstellung und zusammensetzung zur aktivierung gastromotorischer funktionen.
IL149838A0 (en) Novel il-8 receptor antagonists
BR0212932A (pt) Derivados de alquilaminopiridazinona substituìdos, processo para a preparação destes, composição farmacêutica contendo os mesmos e seus usos
MX9200607A (es) 9-amino tetra hidro acridinas y compuestos relacionados, un procedimiento para su preparacion y su uso como medicamentos.
ES2053652T3 (es) N-(alquilideno sustituido)-1,2,3,4,-tetrahidro-9-acridinaminas, un procedimiento para su preparacion y su uso como medicamentos.
NO802325L (no) Fremgangsmaate ved fremstilling av 3-amino-1-benzoxepin-derivater
DE68919280D1 (de) Alpha-adrenergische Rezeptorantagonisten.
AR035022A1 (es) Nitro-sulfobenzamidas, proceso para su fabricacion, y uso de estos compuestos para preparar sulfonilureas
ES557768A0 (es) Un procedimiento para preparar benzo (c)-1,5-naftiridinas
DE68919438D1 (de) Alpha-adrenergische Rezeptorantagonisten.
ES2135383T3 (es) Pirido(3,4-b)pirrolo(1,2-e)(1,4,5)oxadiazepinas y compuestos analogos relacionados, un procedimiento para su preparacion y su uso como medicamentos.
GB959057A (en) Novel substituted ethanolamines and a process for the manufacture thereof
ES422085A1 (es) Procedimiento para preparar amino-acilanilidas primarias.
KR910006295A (ko) 피소스티그민과 관련된 n-아미노카바메이트, 이의 제조방법 및 약제로서의 이의 용도

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 509400

Country of ref document: ES